Skip to content
Abierto
Menu

Award notice, total small business set-aside

Doxycycline hyclate 100 mg oral tablets

75A50325F80009

Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Chartwell RX LLC

$167,964,526.08 on the award notice, June 18, 2025, contract 36F79720D0198

Description

As published on SAM.gov.

This requirement is for the supply of Doxycycline hyclate 100 mg oral tablets.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Chartwell RX LLC
UEI
ER5UA9TYBGH4
CAGE
8APG0
Vendor location
Congers, NY
Contract
75A50325F80009 under 36F79720D0198, delivery order
Obligated
$98,684,252.16, potential $167,964,526
Actions
3 between June 18, 2025 and December 12, 2025
Competition
Full and Open Competition, 2 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
Doxycycline Hyclate 100 MG Oral Tablets
Match
solicitation number 75A50325F80009 was reused as the contract number; same awarding office 75A503 (high confidence)
Record
USAspending award page
Recipient
Chartwell RX LLC
UEI
ER5UA9TYBGH4
CAGE
8APG0
Vendor location
Congers, NY
Contract
36F79720D0198
Obligated
$0.00, potential $449,428,447
Actions
30 between January 16, 2024 and July 7, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
FSS
Match
award number 36F79720D0198 equals the contract number; awarding office not confirmed (medium confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 20, 2025

    Award notice

    Awarded to CHARTWELL RX LLC Congers for $167,964,526. SAM.gov, notice 6cbeecc2ea0848f68a9b514faa6f6823

Also open from this buyer